Glucocorticoid (GC) hormones induce apoptosis in lymphoid and leukemic cells by binding and activating cytosolic GC receptors. Because physiological stress often causes hormone-free GC receptor activation, we have investigated if stress-induced apoptosis of lymphoid cells is also mediated by the activation of the GC receptor pathway. In S49 T lymphoma cells, heat shock and deprivation of growth factors or nutrients caused nuclear translocation and loss of agonist binding capacity of GC receptors, similar to that in cells incubated with the glucocorticoid dexamethasone (DEX). In variant S49 H.2 cells, cross-resistance to DEX, temperature shocks and growth factor deprivation were associated with a higher threshold for hormone-dependent and -independent receptor activation in situ and with impaired in vitro activation of cytosolic receptors. Cross-resistance to DEX, low serum and heat shock was abrogated, however, by pharmacological sensitization of GC receptor activation with the drug meta-iodobenzylguanidine (MIBG). Sensitive S49 cells and resistant variants did not differ in the expression levels of the apoptosis-regulating genes bax, bad, bcl-X and bcl-2, the status of the p53 gene nor in a different requirement for the growth factors Il-2, IL-4 or IL-9. The results suggest that ligand-independent activation of the GC receptor is a central signalling and controlling event in some forms of stress-induced apoptosis, assigning a novel function to the GC receptor in the regulation of lymphoid and leukemic cell numbers.
Introduction
Apoptosis is a major mode of cell death in lymphoid tissues, considered to be essential to the functioning of the immune system 1,2 and responsible for the marked chemosensitivity of its malignant counterparts leukemia and lymphoma. 3, 4 The reason for the particular susceptibility of lymphoid cells to apoptosis is unknown but it has been postulated that they are primed by a default apoptotic mechanism. 4 Lymphoid cells are also uniquely sensitive to apoptosis by glucocorticoid hormones. The only documented function of GC agonists is to activate a heteromeric, 360 kDa cytosolic GC receptor complex. 5 Receptor activation involves the dissociation of two heat shock proteins (HSP90), resulting in the loss of highaffinity hormone binding capacity. Dissociation of HSP90 exposes nuclear location as well as DNA binding motifs on the 96 kDa GC receptor that facilitate its nuclear translocation and interaction with GC-responsive elements. Nuclear translocation has also been observed in the absence of GC agonists, eg after severe energy depletion in WEHI cells, 6 truncation of the receptor gene in S49 nti mutants 7 and after heat shock and chemical stress in CHO cells, transfected with the mouse GC receptor gene. 8 In the latter system, cellular stress caused partial induction of GC-dependent reporter genes, indicating functional activation of the unliganded receptor. Hormone-free receptor activation has also been recently demCorrespondence: LA Smets; Fax: 31 20 51 22 050 Received 29 July 1997; accepted 29 October 1997 onstrated in a more physiological context, ie during spontaneous aggregation of follicular lymphoma cells. 9 These various observations hint at the possibility that multiple physiological but non-hormonal signals could kill lymphoid cells by ligand-independent activation of the GC receptor, leading to apoptosis. The demonstration by Kiefer et al 10 that a functional GC receptor is required for cAMP-mediated apoptosis of T leukemia cells, attests to this idea.
The pathway from GC receptor activation to apoptosis is incompletely known but glucocorticoid action in lymphoid and leukemic cells belongs apparently to a large class of specific and nonspecific apoptotic triggers. 11 In addition, the process is under multiple post-receptor controls. Apoptosis of leukemic cells and normal thymocytes is critically controlled by the expression levels of the genes bcl-2 and bax [12] [13] [14] and exogenous growth factors and mitogenic stimulation can rescue lymphoid cells from both DEX-mediated and spontaneous apoptosis. [15] [16] [17] To investigate if the GC receptor is indeed involved in stress-induced apoptosis, we have studied its subcellular distribution and ligand binding capacity in S49 mouse T lymphoma cells, exposed to heat shock, cold shock, low serum concentration or high cell density. In addition, receptor activation was studied in clonal H.2 variants, selected for crossresistance to DEX and stress conditions while remaining sensitive to several other inducers. These variants resemble the deathless phenotypes isolated from WEHI cells, ie cells that are inhibited in their growth by DEX and cAMP but resist subsequent cell death. 18 To correlate the differential sensitivity of S49 and H.2 cells to stress conditions with the activation probability of the GC receptor complex, the cell lines were compared for in vitro activation of GC receptors in cell-free assays, for nuclear translocation in situ and for the sensitivity to corticosteroids with different agonist potency. In addition, we investigated if pharmacological sensitization of GC receptor activation could simultaneously abrogate resistance to hormone-and stress-mediated apoptosis. Studies on post-receptor controls included the expression levels of pro-apoptotic genes bax and bad and the anti-apoptotic bcl-2 and bcl-X, the status of the p53 gene and the requirement for growth factors in sensitive and resistant cells.
Materials and methods
Cells and culture conditions S49 cells, substrain 49.1, with a doubling time of 12 h, were grown in Dulbecco's modification of Eagle medium, supplemented with 10% fetal calf serum and antibiotics as described previously. 19 Variant cell lines were generated in a protocol that selected for cells which resisted glucocorticoidmediated cell death but remained sensitive to growth inhibition by the steroid. To this end, cells were grown in 10 ). The S-phase specific drug FUdR (10 g/ml) was included during the last 48 h to eliminate DEX-resistant variants that were not growth-arrested by the hormone. Survivors of combined treatment were clonally expanded and after a second round of selection, 20 clones were isolated. All clones were sensitive to FUdR and resistant to DEX as single drugs but two clones were deficient in 3 H-DEX binding. The other clones all contained a full-length, 96 kDa GC receptor in Western blots and had between 12 000 and 22 000 specific 3 H-DEX binding sites per cell. A representative clone H.2 with a doubling time of 20-24 h and containing Ͼ20 000 3 H-DEX binding sites per cell was selected for subsequent studies. All drugs were added as 1000-fold concentrates to exponentially growing cells at a density of 200 000 cells/ml. Growth factor deprivation was achieved by growing cells in a medium containing a critical concentration of 1% fetal calf serum, established in separate experiments. Recombinant murine interleukins, IL-4 and IL-9, were purchased from SanverTECH (Breda, The Netherlands) and IL-2 from Boehringer (Mannheim, Germany). MIBG was from EMKA Chemie (Markgrö ningen, Germany) and all other drugs were from Sigma (St Louis, MO, USA).
Scoring of apoptosis and cell survival Apoptosis was routinely scored by DNA flow cytometry as the fraction of cells with hypodiploid DNA according to Nicoletti et al 20 and qualitatively confirmed as characteristic DNA degradation observed by agarose gel electrophoresis, using methods described by Bissonette et al. 21 Single cell survival was determined by seeding control and treated cells in appropriate dilutions in a semi-solid medium containing 0.6% carboxymethylcellulose. The cells were plated immediately after temperature shocks or after 24 and 48 h of growth in DEXcontaining or low serum medium, respectively. In the latter conditions, the total cell count, including cells with apoptotic morphology, was used for the calculation of the inoculum density. Macroscopic colonies were scored after 10 days. Temperature shocks were performed by incubating concentrated cell suspensions (1 × 10 6 /ml) in a waterbath of 0 or 43°C for the indicated time, interrupted by the addition of a five-fold excess of medium of 37°C.
Glucocorticoid receptor assays
The per cell number of glucocorticoid receptors was determined in whole-cell 3 H-DEX binding assays at room temperature as described. 19 In studies involving DEX-exposed cells, the hormone was also added to control cultures immediately before cell harvest by centrifugation. Nuclear translocation of the cytosolic GC receptor was probed in Western blots of 500 mM KCl extractable proteins from nuclear fractions, using methods described previously. 19 Immunoblotting was performed with monoclonal antibody GR49, kindly donated by Dr Westphal (Philipps Universität, Marburg, Germany), on the protein equivalent of 1 × 10 6 cells or on the equivalent of 1 × 10 7 cells with antiserum MAI-510, clone BuGR2 (Affinity Bioreagents, Neshanic Station, USA). Proteins were visualized with ECL or with 125 I-IgG, followed by quantitation with phosphorimaging. Activation in vitro was assayed as the binding to DNA-cellulose of cytosolic receptors, first complexed with 3 H-DEX for 2 h at 0°C and subsequently heated at 20°C as described previously. 22 At indicated times, aliquots of the cytosol were passed on mini-columns of DNA-cellulose (Pharmacia, Uppsala, Sweden) or DEAE-sepharose to determine activated, DNA-binding 3 H-DEX-labelled proteins in per cent of total labelled protein, retained by DEAE.
Bcl-2 and homologues and p53 status Protein levels of Bcl-2, Bcl-X, Bad and Bax were estimated in cell lysates by immunoblot analysis using a mouse-specific anti-Bcl-2 antibody (4C11) and cross-reacting anti-Bax (N20) and anti-Bcl-X (SC-634) from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and anti-Bad (B36420) from Transduction Laboratories (Lexington, KY, USA). The blots were developed and protein levels were determined using methods described in the previous paragraph. DNA sequence analysis was performed on p53 exons 5-9 PCR products. The PCR conditions were: 30 cycles: 0.5 min 96°C, 0.5 min 60°C, 1 min 72°C; sense primer 5′TGCA(G/T)TCTGGGACAGCCAAG and antisense primer 5′AGGGTGAAATA(G/T)TCTCCATC. The products were cloned into the TA vector (Invitrogen, San Diego, CA, USA) and sequenced using T7 polymerase (Pharmacia Biotech).
Results
Agonist-free receptor activation and apoptosis S49 cells exposed to DEX (10 −7 M) exhibited characteristic alterations in nuclear morphology, formation of DNA ladders from internucleosomal degradation on PAGE and the appearance of cells with hypodiploid DNA content, similar to that described for these cells by Hughes and Cidlowski. 23 DEX also induced rapid nuclear translocation of part of the cytosolic GC receptors, which relocated to the cytosol upon removal of the hormone during the induction phase of about 8-10 h.
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S49 cells were also sensitive to growth factor deprivation, achieved by growing the cells in medium containing 1% serum, or exposure to cold or heat as described in the next paragraph. Figure 1 illustrates that low serum and heat shock caused nuclear translocation of the GC receptor to a much greater extent than in DEX-treated cells. Nuclear translocation was observed within 20 min after addition of DEX and immediately after a heat shock but only after several h of growth in low serum medium. In all cases, nuclear translocation was accompanied by a proportional reduction in the number of specific 3 H-DEX binding sites. Because the association with HSP90 is essential for maintaining the high-affinity binding state, 5, 9, 24 the translocated receptors in stressed cells were apparently fully activated. Ligand-independent nuclear translocation and downregulation of 3 H-DEX binding was also observed in S49 cells grown in 5 days from an inoculum of 1 × 10 5 cells/ml to a stationary density of 3.5 × 10 6 cells/ml but not so in cells kept at 0°C for 120 min. The latter observation is in agreement with the absence of a GC receptor signal in nuclei from control cells, subjected to repeated washing in cold buffer during the preparation of nuclear fractions ( Figure 1, lane 1) . However, neither nuclear translocation nor loss of binding capacity were specific for GC-treated or stressexposed cells. These phenomena were consistently found in all cell populations containing detectable fractions of hypodiploid, apoptotic cells after several types of cellular insult, including X-rays and cytostatic drugs as described below. Cross-resistance to DEX and physiological stress To establish a causal role of ligand-independent receptor activation in stress-induced apoptosis, we isolated GC receptorpositive but DEX-resistant variants as described in the Materials and methods section. The results with the representative cell line S49 H.2 revealed that cells selected for DEX resistance ( Figure 2a) were cross-resistant to apoptosis by low serum (Figure 2b ) and much less sensitive to cold or heat shock ( Figure 3 ). Cross-resistance to DEX, low serum and heat was tested and confirmed in six clones from which clone H.2 was selected for having the highest number of 3 H-DEX binding sites. The only detectable effect of DEX and low serum was to increase the population doubling time from 22 to about 40 h. DNA degradation characteristic of apoptosis was observed in cold-or heat-shocked S49 cells within 2 h after plating in medium of 37°C, but apoptotic cells with hypodiploid DNA content were detectable not earlier than 6 h after plating, similar to that described for cold-shocked Burkitt lymphoma cells. 4 Because of a longer cell cycle time, H.2 cells may not differ from parent S49 cells in the intrinsic sensitivity to the various treatments but only in the kinetics of apoptosis. To test this single cell survival was determined after critical treatment conditions, based on the results shown in Figures 2 and 3 . The surviving cell fraction (SF; mean ± s.e.m. of four independent 
Sensitivity to pharmacological inducers
Stress-resistant H.2 cells were sensitive to several pharmacological inducers of apoptosis and radiation ( mally effective concentrations of the various drugs to initiate an apoptotic response. However, with most drugs the rate of apoptosis in H.2 cells was clearly delayed and thus the level of apoptotic cells at fixed time intervals. Because the cell lines did not differ markedly in clonogenic survival after 24 h exposure to vincristin (D 0 = 0.03 g/ml) or X-rays (D 0 = 2 Gy), the differences in the levels of apoptosis are ascribed mainly to the longer cell cycle time of H.2 cells.
Different threshold for GC receptor activation
In agreement with the unchanged 3 H-DEX binding properties, Western blotting confirmed that H.2 cells contained a fulllength cytosolic receptor protein ( Figure 5 top panel) . In contrast to the findings in parent S49 cells (Figure 1 ), DEX and low serum failed to induce nuclear translocation of the GC receptor in H.2 cells. GC receptors from H.2 cells also resisted in vitro activation, determined as the acquisition of DNAbinding capacity of 3 H-DEX complexed, cytosolic receptors ( Figure 5 bottom panel) . Next, the cell lines were exposed to GC agonists of different activity. These included the strong agonist cortivazol (CV), which is able to lyse DEX-resistant CEM cells, 28 and the weak antagonist cortexolone (CTX), which has latent agonist activity in rat thymocytes. 29 S49 cells were fully sensitive to 10 −7 M CV or DEX and even partially to 10 −6 M CTX. By contrast, H.2 cells were only susceptible to 10 −6 M CV, and this response was effectively blocked by a 10-fold excess of the strong antagonist RU484 (data not shown). Collectively, the results suggest that H.2 cells had an elevated threshold for DEX-mediated receptor activation but were basically competent in an apoptotic response to a more potent agonist or to pharmacological inducers and cytostatic treatment ( Table 1 ).
Abrogation of cross-resistance to DEX and stress factors
To investigate if an elevated threshold for receptor activation was also involved in the cross-resistance to temperature shocks and growth factor deprivation, H.2 cells were incubated with the mitochondriotropic drug MIBG. In related L1210 lymphoma cells, MIBG abrogates resistance to DEX, restores the in vitro activation of cytosolic receptors and converts the antagonist RU484 into a potent agonist. 22 MIBG also sensitized resistant S49 H.2 cells not only to DEX but also to low serum that heat shock, but not so to cold shock ( Figure 6 ). To assess for nonspecific effects that may have resulted from the documented antimitochondrial activity of MIBG, 30 control studies were performed with the mitochondrial inhibitor rotenone which also acts on complex I of mitochondrial respiration and has comparable effects on cellular energy charge in a concentration of 10 −6 M.
14 MIBG and rotenone alone were minimally toxic to both S49 and H.2 cells (Figure 6 , controls) but rotenone did not abrogate resistance to DEX and low serum.
To confirm that MIBG promoted both hormonal and nonhormonal GC receptor activation, H.2 cells were preincubated with the drug for 16 h and tested for in vitro activation of cytosolic receptors or loss of 
Expression of apoptosis-regulating genes and effect of growth factors
To assess a possible contribution of post-receptor controls, protein levels of Bcl-2 and homologues and the status of the p53 gene were determined. Bcl-2 protein was barely expressed in S49 and H.2 variants, nor was it upregulated in the resistant cells during prolonged exposure to DEX or low serum (Figure 8) . Resistance in H.2 cells was not associated with a paucity of the apoptosis-promoting protein, Bax. Bax was expressed in S49 and in H.2 cells and the levels were, in fact, higher than in two reference leukemic cells lines using quantitative analysis by phosphorimaging (Figure 8b ). S49 cells and variants also expressed low levels of the anti-apoptotic Bcl-X and high levels of pro-apoptotic Bad compared to the reference DoHH2 cells. In accordance with the apoptotic response to DNA-damaging agents (Table I) , analyses of p53 cDNA revealed a sequence identical to the wild-type configuration described by Bienz et al. 31 Unlike studies with activated or mature T lymphocytes and with T hybridomas, 15, 16, 32 the murine interleukins IL-2 (50-400 U/ml), IL-4 (1-25 ng/ml) or IL-9 (0.25-25 ng/ml) alone or in various combinations did not afford protection against DEX or growth factor deprivation in S49 cells, nor did the supernatant medium harvested from H.2 cultures (data not shown).
Discussion
In the present study, we have investigated if lymphoid cells can utilize the GC receptor pathway for the execution of a programmed cell death in response to physiological stress. Attesting to this hypothesis was the observation that apoptosis of S49 cells by low serum, heat shock and high cell density was accompanied by key steps in the activation of the GC receptor: nuclear translocation and loss of agonist binding activity (Figure 1) . However, the level of receptor activation in serum-deprived or heat-shocked cells far exceeded that required to initiate apoptosis by DEX, and nuclear translocation and loss of agonist binding capacity were also observed after various other types of cytotoxic insult. Ligand-free GC receptor activation in stressed cells may therefore be mainly a consequence of metabolic perturbations in dying cells. On the other hand, the heat-treated cells were fully intact at the time of receptor studies and agonist-free GC receptor activation has also been clearly demonstrated in essentially viable populations, eg biochemically in aggregated lymphoma cells 9 and functionally in non-lymphoid CHO cells transfected with GC-sensitive CAT reporter constructs. 8 The studies with H.2 variant cells provided more direct evidence that the GC receptor can be instrumental in some forms of stress-mediated apoptosis. These cells were characteristically cross-resistant to DEX, low serum and temperature shocks and differed from sensitive S49 cells by an elevated threshold for DEX-mediated nuclear translocation and the in vitro activation of the GC receptor. Moreover, H.2 cells were also less sensitive to downregulation of 3 H-DEX binding capacity by heat shock. Because of the long induction time, the evidence for a causal involvement of agonist-free GC receptor in low serum-induced apoptosis was only indirect, namely the cross-resistance of H.2 cells to low serum, DEX and heat and the simultaneous sensitization to these conditions by the drug MIBG ( Figure 6 ). Similar to what was observed in related L1210 variants, 22 MIBG restored the in vitro activation of cytosolic GC receptors from H.2 cells and promoted the loss of 3 H-DEX binding after heat shock. Despite a large difference in the rate of apoptosis, cold shock was equitoxic for the survival of S49 and H.2 cells. Moreover, a cold shock induced neither (early) nuclear translocation nor loss of 3 H-DEX binding and subsequent apoptosis was not potentiated by MIBG. The cytotoxic mechanism of cold shock in these and some other cell lines 4 is unknown by apparently unrelated to GC receptor activation in the S49 cells. The delayed response to cold of the more slowly growing H.2 cells suggests that some form of cell cycle deregulation may be involved instead.
Previous studies have indicated that GC receptor activation in S49 cells is a highly dynamic, cyclic and thermolabile pro- cess and that triggering to apoptosis is dependent on a critical minimum in time and amount of receptor activation. 19 Although stress conditions and the drug MIBG could influence this delicate balance at multiple points, it is of note that heat shock proteins are major acceptors of adenosine phosphates, resulting in post-translational mono(ADP-ribosylation). Heat shock or glucose deprivation cause rapid, post-translational decrease of the mono(ADP-ribosylation) of heat shock proteins in various cells 33 and MIBG is a known inhibitor of cellular mono(ADP-ribosylation). 34 Accordingly, a decrease in the level of mono(ADP-ribose) adducts in GC receptor-associated HSP90 proteins could possibly be a common stress-sensing event and the target process of MIBG action, eg by inhibiting the reassociation of the heat-activated receptor complexes (Figure 7) . At minimally toxic doses the antimitochondrial drug rotenone did not reproduce the potentiations by MIBG, but has comparable effects on cellular ATP content in these 17 and other cell lines.
14 This observation and the failing potentiation by MIBG to cold argue against an important role of antimitochondrial effects of MIBG in the potentiation of Bcl-2-negative S49 variants, contrary to previous findings in Bcl-2 overexpressing lymphoma cells. 14 While admittedly incomplete, the present studies did not reveal an important role of post-receptor controls in the differential sensitivity of S49 cells and H.2 variants. Both cell lines expressed high levels of the pro-apoptotic proteins, Bax and Bad and low levels of anti-apoptotic Bcl-X and Bcl-2, which is a potent suppressor of apoptosis in these cells. 12, 23 Because Bcl-2 and family members protect against a wide spectrum of inducers, including cytostatic drugs 12 and TG, 27 it is unlikely that resistance of H.2 cells was due to enhanced expression of other, Bcl-2-related anti-apoptotic proteins. Conceptually, cross-resistance of H.2 cells could be due to autocrine production of growth/survival factors, which can rescue several cells of T origin from apoptosis by DEX and low serum. [15] [16] [17] Because interleukins have been reported to protect T cells by maintaining or upregulating Bcl-2 levels, 15,32 the failure to rescue S49 cells from DEX and low serum by exogenous interleukins, and by inference the H.2 cells by autocrine growth factors, may be attributed to the intrinsically low expression of the bcl-2 gene.
Although the generality of the present observations remains to be established, ligand-free activation of the GC receptor by stress conditions may link the unique sensitivity of lymphoid/leukemic cells to GC-mediated lysis with their overall high propensity to apoptosis. Our observations are in agreement with the reported cross-resistance to DEX and cAMP in WEHI cells 18 and with the requirement of a functional GC receptor in cAMP-mediated apoptosis of CEM cells. 10 Whereas these findings have been interpreted as shared distal events or molecular cross-talk between independent pathways, respectively, they also fit the herepresented scenario that multiple signals can initiate apoptosis of lymphoid and leukemic cells by ligand-free activation of the GC receptor. If confirmed, our observations would assign a novel function to the GC receptor in the regulation of lymphoid and leukemic cell numbers, namely to execute or accelerate a cell death programme in response to stress conditions.
